Sage Therapeutics, Inc. (SAGE) Social Stream
SAGE THERAPEUTICS INC (SAGE) Price Targets From Analysts
Use the tables below to see what analysts covering SAGE THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-01 | 20 | $105 | $48 | $73.368 | $49.56 | 48.04% |
| 2021-12-20 | 20 | $105 | $48 | $72.842 | $49.56 | 46.98% |
| 2022-01-12 | 19 | $105 | $48 | $73.157 | $49.56 | 47.61% |
| 2022-01-26 | 17 | $105 | $48 | $73.157 | $49.56 | 47.61% |
| 2022-02-16 | 17 | $105 | $48 | $72.315 | $49.56 | 45.91% |
| 2022-02-25 | 18 | $105 | $48 | $71.736 | $49.56 | 44.75% |
| 2022-02-28 | 17 | $105 | $48 | $70.055 | $49.56 | 41.35% |
| 2022-03-21 | 17 | $105 | $40 | $68.722 | $49.56 | 38.66% |
| 2022-04-01 | 18 | $105 | $37 | $67.052 | $49.56 | 35.29% |
| 2022-05-03 | 18 | $105 | $37 | $67.21 | $49.56 | 35.61% |
| 2022-05-04 | 18 | $105 | $37 | $65.7 | $49.56 | 32.57% |
| 2022-05-06 | 18 | $105 | $37 | $64.631 | $49.56 | 30.41% |
| 2022-05-10 | 18 | $105 | $37 | $64.421 | $49.56 | 29.99% |
| 2022-05-24 | 19 | $105 | $37 | $64.85 | $49.56 | 30.85% |
| 2022-06-01 | 19 | $105 | $37 | $65 | $49.56 | 31.15% |
| 2022-06-13 | 18 | $105 | $36 | $63.5 | $49.56 | 28.13% |
| 2022-07-21 | 18 | $105 | $36 | $61 | $49.56 | 23.08% |
| 2022-08-03 | 18 | $105 | $36 | $57.941 | $49.56 | 16.91% |
| 2022-08-04 | 18 | $105 | $36 | $59.611 | $49.56 | 20.28% |
| 2022-09-19 | 18 | $105 | $36 | $59.5 | $49.56 | 20.06% |
| 2022-10-17 | 16 | $105 | $36 | $59.5 | $49.56 | 20.06% |
| 2022-11-01 | 16 | $105 | $36 | $59.111 | $49.56 | 19.27% |
| 2022-11-08 | 17 | $105 | $36 | $59.111 | $49.56 | 19.27% |
| 2022-11-11 | 18 | $105 | $36 | $57 | $49.56 | 15.01% |
| 2022-11-21 | 19 | $105 | $36 | $56.85 | $49.56 | 14.71% |
| 2022-12-07 | 20 | $105 | $36 | $55 | $49.56 | 10.98% |
| 2023-02-06 | 20 | $105 | $36 | $55.3 | $49.56 | 11.58% |
| 2023-02-17 | 20 | $105 | $36 | $55.5 | $49.56 | 11.99% |
| 2023-02-21 | 21 | $105 | $36 | $56.05 | $49.56 | 13.1% |
| 2023-03-10 | 21 | $105 | $36 | $56.1 | $49.56 | 13.2% |
| 2023-03-13 | 22 | $105 | $36 | $56.285 | $49.56 | 13.57% |
| 2023-05-03 | 22 | $105 | $36 | $57.65 | $49.56 | 16.32% |
| 2023-05-04 | 22 | $105 | $40 | $57.8 | $49.56 | 16.63% |
| 2023-05-09 | 22 | $105 | $40 | $56.894 | $49.56 | 14.8% |
| 2023-05-22 | 21 | $105 | $40 | $56.947 | $49.56 | 14.91% |
The Trend in the Analyst Price Target
Over the past 16 months, SAGE's average price target has gone down $15.41.
Over the past 49 weeks, SAGE's average upside potential has been 43.17%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-06-13 | 18 | 105 | 36 | 63.500 | 32.00 | 98.44% |
| 2022-09-10 | 18 | 105 | 36 | 59.500 | 42.00 | 41.67% |
| 2023-03-10 | 21 | 105 | 36 | 56.100 | 39.56 | 41.81% |
| 2023-05-09 | 22 | 105 | 40 | 56.894 | 50.66 | 12.31% |
| 2023-05-22 | 22 | 105 | 40 | 56.947 | 53.38 | 6.68% |
SAGE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.18 | 8 | 2 | 12 | 0 | 0 | 22 |
The Trend in the Broker Recommendations
Over the past 14 months, SAGE's average broker recommendation rating worsened by 0.06.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SAGE as an investment opportunity.
- In terms of how SAGE THERAPEUTICS INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 4578% of that group.
- SAGE has a lower variance in analysts' estimates than -4328.44% of stocks in the mid market cap category.
- In the context of Pharmaceutical Products stocks, SAGE THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1015.03% of them.
- SAGE has a higher average analyst price target than 3796.94% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, FGEN, TARO, and ITCI are the three stocks most similar to SAGE THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is SAGE a Buy, Hold or Sell? See the POWR Ratings now!